Changes of serum omentin-1 levels and relationship between omentin-1 and insulin resistance in chronic hepatitis C patients

EXCLI Journal

Volumn 12, Issue , 2013, Pages 924-932

  Hussein Nassif, Walaa Moustafa ^a   Ismail Amin, Ashraf ^b   Abdeltawab Hassan, Zeinab ^a   Abdelhafiz Abdelaziz, Dalia Hussein ^a  

^a HELWAN UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Hepatitis C; Insulin resistance; Omentin 1; Type 2 diabetes

Indexed keywords

ADIPOCYTOKINE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; OMENTIN 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HEPATITIS C; HUMAN; INSULIN RESISTANCE; LIVER FUNCTION; MALE; METABOLIC DISORDER; PATHOGENESIS; PROTEIN BLOOD LEVEL;

EID: 84887005777     PISSN: None     EISSN: 16112156     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20: 470-5.
2. Bertolani C, Marra F. The role of adipokines in liver fibrosis. Pathophysiology 2008;15:91-101.
3. Burstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1970;11:583-95.
4. Caldwell S, Ikura Y, Dias D, Isomoto K, Yabu A, Moskaluk C et al. Hepatocellular ballooning in NASH. J Hepatol 2010;53: 719-23.
5. Castelli WP, Doyle JT, Gordon T, Hames CG, Hjortland MC, Hulley SB et al. Alcohol and blood lipids. The cooperative lipoprotein phenotyping study. Lancet 1977;2: 153-5.
6. De Souza Batista CM, Yang R-Z, Lee M-J, Glynn NM, Yu D-Z, Pray J et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes 2007;56: 1655-61.
7. Eisinger K, Krautbauer S, Wiest R, Karrasch T, Hader Y, Scherer MN et al. Portal vein omentin is increased in patients with liver cirrhosis but is not associated with complications of portal hypertension. Eur J Clin Invest 2013;43:926-32.
8. El-Mesallamy HO, El-Derany MO, Hamdy NM. Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart disease. Diabet Med 2011;28:1194-200.
9. Fartoux L, Poujol-Robert A, Guéchot J, Wendum D, Poupon R, Serfaty L. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Gut 2005;54:1003-8.
10. Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982;28:2077-80.
11. Gürsoy G, Ki{dotless}rnap NG, Esbah O, Acar Y, Demirbas B, Akçayöz S et al. The relationship between plasma omentin-1 levels and insulin resistance in newly diagnosed type 2 diabetic women. Clin Rev Opin 2010;2:49-54.
12. Hui JM, Sud A, Farrell GC, Bandara P, Byth K, Kench JG et al. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression. Gastroenterology 2003;125:1695-704.
13. Jeppsson JO, Jerntorp P, Sundkvist G, Englund H, Nylund V. Measurement of hemoglobin A1c by a new liquid-chromatographic assay: methodology, clinical utility, and relation to glucose tolerance evaluated. Clin Chem 1986;32:1867-72.
14. Kawaguchi T, Ide T, Taniguchi E, Hirano E, Itou M, Sumie S et al. Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2. Am J Gastroenterol 2007;102:570-6.
15. Kukla M, Zwirska-Korczala K, Gabriel A, Waluga M, Warakomska I, Szczygiel B et al. Chemerin, vaspin and insulin resistance in chronic hepatitis C. J Viral Hepat 2010; 17:661-7.
16. Kuperman DA, Lewis CC, Woodruff PG, Rodriguez MW, Yang YH, Dolganov GM et al. Dissecting asthma using focused transgenic modeling and functional genomics. J Allergy Clin Immunol 2005;116: 305-11.
17. Marra F, Bertolani C. Adipokines in liver diseases. Hepatology 2009;50:957-69.
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
19. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000;133:592-9.
20. Pan H-Y, Guo L, Li Q. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract 2010;88:29-33.
21. Perlemuter G, Sabile A, Letteron P, Vona G, Topilco A, Chrétien Y et al. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J 2002;16:185-94.
22. Rabe K, Lehrke M, Parhofer KG, Broedl UC. Adipokines and insulin resistance. Mol Med 2008;14:741-51.
23. Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol 1957;28: 56-63.
24. Schäffler A, Neumeier M, Herfarth H, Fürst A, Schölmerich J, Büchler C. Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta 2005;1732: 96-102.
25. Simó R, Lecube A, Genescà J, Esteban JI, Hernández C. Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection. Diabetes Care 2006;29:2462-6.
26. Tan BK, Adya R, Farhatullah S, Lewandowski KC, O'Hare P, Lehnert H et al. Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes 2008a;57:801-8.
27. Tan BK, Pua S, Syed F, Lewandowski KC, O'Hare JP, Randeva HS. Decreased plasma omentin-1 levels in type 1 diabetes mellitus. Diabet Med 2008b;25:1254-5.
28. Torres DM, Harrison SA. Hepatitis C virus and insulin resistance/diabetes mellitus. Gastroenterol Hepatol 2008;4:568-70.
29. Tsuji S, Yamashita M, Hoffman DR, Nishiyama A, Shinohara T, Ohtsu T et al. Capture of heat-killed Mycobacterium bovis bacillus Calmette-Guérin by intelectin-1 deposited on cell surfaces. Glycobiology 2009;19:518-26.
30. Wali A, Morin PJ, Hough CD, Lonardo F, Seya T, Carbone M et al. Identification of intelectin overexpression in malignant pleural mesothelioma by serial analysis of gene expression (SAGE). Lung Cancer 2005;48:19-29.
31. WHO, World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/international Diabetes Federation consultation. Geneva: WHO, 2006.
32. Yan P, Liu D, Long M, Ren Y, Pang J, Li R. Changes of serum omentin levels and relationship between omentin and adiponectin concentrations in type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2011;119:257-63.
33. Yang R-Z, Lee M-J, Hu H, Pray J, Wu HB, Hansen BC et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol 2006;290:E1253-61.
34. Yilmaz Y, Yonal O, Kurt R, Alahdab YO, Eren F, Ozdogan O et al. Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease. Scand J Gastroenterol 2011;46:91-7.
35. Zhang Y-Y, Zhou L-M. Omentin-1, a new adipokine, promotes apoptosis through regulating Sirt1-dependent p53 deacetylation in hepatocellular carcinoma cells. Eur J Pharmacol 2013;698:137-44.